One notable difference between the two groups was the absence of FcγR expression on the AML blasts of CD123-IgG1+-responders and its presence in CD123-IgG1+-nonresponders, whose cells expressed CD32 (a and/or b isoforms) and/or CD64 (Fig. 1b). This evidence concerns the gene FCGR2B and acute myeloid leukemia.